NOUSHIN EMAMI: Open Payments
NPI 1356052369 · SURPRISE, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,624 in 65 payments from 15 companies in 2025. Trend: 2023 $189 · 2024 $1,225 · 2025 $2,624
Food & beverage: $1,732Travel & lodging: $892
| Company | Payments | Amount |
|---|---|---|
| Medtronic, Inc. | 15 | $1,319 |
| ABBVIE INC. | 21 | $501 |
| Abbott Laboratories | 3 | $265 |
| Globus Medical, Inc. | 5 | $163 |
| Novo Nordisk Inc | 4 | $70 |
| GlaxoSmithKline, LLC. | 4 | $64 |
| PFIZER INC. | 3 | $63 |
| AstraZeneca Pharmaceuticals LP | 3 | $43 |
| Eisai Inc. | 1 | $29 |
| Nalu Medical, Inc. | 1 | $23 |
Products named: INTELLIS ADAPTIVESTIM, VRAYLAR, PROCLAIM, INCEPTIV, Senza, KYPHON EXPRESS II KYPHOPAK TRAY, QULIPTA, PREVNAR 20.
Industry payments across AZ — which companies pay providers there.
